UBS Group’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-294,314
| Closed | -$4.63M | – | 11771 |
|
|
2022
Q2 | $4.63M | Buy |
294,314
+46,396
| +19% | +$708K | ﹤0.01% | 2444 |
|
|
2022
Q1 | $3.77M | Buy |
247,918
+214,440
| +641% | +$3.27M | ﹤0.01% | 2817 |
|
|
2021
Q4 | $515K | Sell |
33,478
-29,900
| -47% | -$393K | ﹤0.01% | 4955 |
|
|
2021
Q3 | $552K | Sell |
63,378
-79,971
| -56% | -$729K | ﹤0.01% | 4665 |
|
|
2021
Q2 | $1.46M | Sell |
143,349
-28,521
| -17% | -$301K | ﹤0.01% | 3852 |
|
|
2021
Q1 | $2.05M | Buy |
171,870
+112,899
| +191% | +$1.28M | ﹤0.01% | 3543 |
|
|
2020
Q4 | $536K | Buy |
58,971
+44,641
| +312% | +$345K | ﹤0.01% | 4548 |
|
|
2020
Q3 | $87K | Sell |
14,330
-25,087
| -64% | -$191K | ﹤0.01% | 5271 |
|
|
2020
Q2 | $350K | Buy |
39,417
+12,755
| +48% | +$110K | ﹤0.01% | 4407 |
|
|
2020
Q1 | $193K | Sell |
26,662
-25,553
| -49% | -$189K | ﹤0.01% | 4754 |
|
|
2019
Q4 | $461K | Buy |
52,215
+40,299
| +338% | +$302K | ﹤0.01% | 4909 |
|
|
2019
Q3 | $73K | Buy |
11,916
+2,553
| +27% | +$14.3K | ﹤0.01% | 5967 |
|
|
2019
Q2 | $39K | Buy |
9,363
+3,901
| +71% | +$20.6K | ﹤0.01% | 6127 |
|
|
2019
Q1 | $35K | Sell |
5,462
-12,745
| -70% | -$89.3K | ﹤0.01% | 5818 |
|
|
2018
Q4 | $118K | Buy |
18,207
+5,630
| +45% | +$43.1K | ﹤0.01% | 5402 |
|
|
2018
Q3 | $105K | Buy |
12,577
+3,355
| +36% | +$25.5K | ﹤0.01% | 5567 |
|
|
2018
Q2 | $58K | Buy |
9,222
+6,722
| +269% | +$42.7K | ﹤0.01% | 5869 |
|
|
2018
Q1 | $17K | Sell |
2,500
-3,783
| -60% | -$24K | ﹤0.01% | 6525 |
|
|
2017
Q4 | $41K | Buy |
6,283
+1,169
| +23% | +$7.14K | ﹤0.01% | 6014 |
|
|
2017
Q3 | $29K | Buy |
5,114
+4,004
| +361% | +$27K | ﹤0.01% | 6192 |
|
|
2017
Q2 | $9K | Sell |
1,110
-2,291
| -67% | -$19.4K | ﹤0.01% | 6861 |
|
|
2017
Q1 | $31K | Sell |
3,401
-3,634
| -52% | -$37.9K | ﹤0.01% | 5845 |
|
|
2016
Q4 | $76K | Buy |
7,035
+5,269
| +298% | +$70.3K | ﹤0.01% | 5493 |
|
|
2016
Q3 | $29K | Sell |
1,766
-14,556
| -89% | -$205K | ﹤0.01% | 5978 |
|
|
2016
Q2 | $155K | Buy |
+16,322
| New | +$178K | ﹤0.01% | 4715 |
|
|
2015
Q2 | – | Sell |
-6,995
| Closed | -$47K | – | 8963 |
|
|
2015
Q1 | $47K | Buy |
+6,995
| New | +$28.1K | ﹤0.01% | 6119 |
|
Other funds holding NPTN
UBS Group's NPTN Position: Q3 2022 in Review
UBS Group sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 294,314 shares — an estimated $4.63M sold.
UBS Group first reported a position in NPTN in Q1 2015 and held it in 26 quarters. The position peaked at $4.63M in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.
- UBS Group reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
- UBS Group sold 294,314 NEOPHOTONICS CORP shares in Q3 2022, an estimated $4.63M.
- UBS Group first reported a position in NEOPHOTONICS CORP in Q1 2015 and held it in 26 quarters.
- UBS Group's NEOPHOTONICS CORP position peaked at $4.63M in Q2 2022.
- 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.
Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.